How has been the historical performance of Ipca Labs?

Answer:The historical performance of Ipca Labs shows a consistent growth trend in net sales and profits over the years, with some fluctuations in specific metrics.

Breakdown:
Ipca Labs has demonstrated significant growth in net sales, increasing from 3,773.18 Cr in Mar'19 to 8,939.59 Cr in Mar'25. The total operating income followed a similar upward trajectory, reaching 8,939.59 Cr in Mar'25, compared to 4,648.71 Cr in Mar'20. The total expenditure also rose, from 3,081.30 Cr in Mar'19 to 7,213.45 Cr in Mar'25, reflecting the company's expansion efforts. Operating profit, excluding other income, increased from 691.88 Cr in Mar'19 to 1,726.14 Cr in Mar'25, indicating improved operational efficiency. However, profit before tax showed variability, peaking at 1,388.98 Cr in Mar'21 before declining to 1,131.14 Cr in Mar'25. The profit after tax also fluctuated, with a high of 1,148.84 Cr in Mar'21 and a subsequent decrease to 787.53 Cr in Mar'25. The earnings per share (EPS) rose from 35.21 in Mar'19 to 29.08 in Mar'25, despite a peak of 89.87 in Mar'21. The operating profit margin improved from 18.34% in Mar'19 to 19.31% in Mar'25, while the profit after tax margin increased from 11.72% to 8.81% over the same period. Overall, Ipca Labs has shown a robust growth trajectory in sales and profits, despite some fluctuations in profitability metrics.